Parkinson's disease drugs Flashcards
Causes of Parkinsonism
Parkinson’s disease
Antipsychotics
Vascular - mainly affecting pons
Progressive supranuclear palsy - eye movement disorders and truncal rigidity
Multiple systems atrophy - severe autonomic dysfunction
Corticobasal degeneration
What does a DAT scan show
Presynaptic dopamine uptake
MoA of levidopa
Crosses BBB to enter CNS and converted to dopamine
Taken up by dopaminergic neurones in substantia nigra (degenerated in disease so variable effects)
How much levidopa enters CNS
<1%
What must be given with levidopa and why
Peripheral DOPA decarboxylase inhibitor e.g Co-careldopa
Or
Catechol-O-methyl transferase inhibitor e.g entacapone
To increase CNS uptake of levidopa and reduce side effects
Benefits of levidopa
Efficacious
Low risk of side effects
Disadvantages of levidopa
Motor symptoms fluctuate as blood level fluctuate
Efficacy decreases over time
Involuntary movements
Drug interactions of levidopa
Vitamin B6 increases peripheral levidopa breakdown
Antipsychotics block dopamine receptors
MAOIs - increased risk of hypertensive crisis
Examples of tablet forms of dopamine agonist
Ropinirole
Pramipexole
Example of patch form of dopamine agonist
Rotigitine
Advantages of dopamine agonists
Less dyskinesia
Disadvantages of dopamine agonists
Not as efficacious as levidopa
Impulse control/reward system dysfunction
More psychiatric side effects (dose limiting)
Side effects of dopamine agonist
Sedation Hypotension Nausea Hallucinations Confusion
Examples of monoamine oxidase B inhibitors
Selegiline
Rasagaline
MoA of MOAIs in Parkinson’s disease and when are they indicated
Decrease dopamine breakdown in brain
Used to prolong action of levidopa if having motor fluctuations